During the past decade, Highland Clinic conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 25 clinical trials were completed, i.e. on average, 833.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 9 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Highland Clinic" #1 sponsor was "National Cancer Institute (NCI)" with 18 trials, followed by "SWOG Cancer Research Network" with 11 trials sponsored, "Alliance for Clinical Trials in Oncology" with 3 trials sponsored, "Dendreon" with 2 trials sponsored and "Spectrum Pharmaceuticals, Inc" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Highland Clinic" #1 collaborator was "National Cancer Institute (NCI)" with 14 trials as a collaborator, "Cancer and Leukemia Group B" with 3 trials as a collaborator, "Eastern Cooperative Oncology Group" with 3 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator and "NRG Oncology" with 3 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Highland Clinic" are "Breast Cancer" (6 trials), "Prostate Cancer" (5 trials), "Metastatic Cancer" (3 trials), "Breast Adenocarcinoma" (2 trials) and "Clear Cell Renal Cell Carcinoma" (2 trials). Many other conditions were trialed in "Highland Clinic" in a lesser frequency.

Most popular intervention types in "Highland Clinic" are "Drug" (34 trials), "Other" (20 trials), "Biological" (12 trials), "Dietary Supplement" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (12 trials), "Bevacizumab" (7 trials), "Quality-of-Life Assessment" (7 trials), "placebo" (7 trials) and "Paclitaxel" (5 trials). Other intervention names were less common.

The vast majority of trials in "Highland Clinic" are 27 trials for "All" genders, 8 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Highland Clinic". undefined are not yet recruiting, 1 are recruiting, 13 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Highland Clinic, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Highland Clinic, 1 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".